CDC Resources

  • Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older
    During this COCA Call, presenters will discuss CDC’s new guidance on bivalent COVID-19 booster doses for people ages 12 years and older, including those who are moderately or severely immunocompromised.
  • Implementation of Personal Protective Equipment (PPE) Use in Nursing Homes to Prevent Spread of Multidrug-resistant Organisms (MDROs)
    Residents in nursing homes are at increased risk of becoming colonized and developing infection with MDROs. This resource provides various precautions for residents and staff.
  • Treatment Information for Healthcare Professionals
    Guidance on the following: Interim Clinical Guidance for the Treatment of Monkeypox, Medical Countermeasures Available for the Treatment of Monkeypox, Tecovirimat, Vaccinia Immune Globulin Intravenous (VIGIV), Cidofovir, Brincidofovir
  • Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Monkeypox Outbreak
    This document provides interim guidance regarding use of JYNNEOS and ACAM2000 vaccines during the monkeypox outbreak that began in the United States on May 17, 2022.
  • Infection Prevention and Control of Monkeypox in Healthcare Settings
    A summary of recommendations for Monkeypox in healthcare settings including, surveillance precautions, PPE, visitation, etc.
  • Monkeypox in the United States: What Clinicians Need to Know, June 2022
    An overview of Monkeypox including how to diagnose and treat infection.
  • COVID-19 Rebound After Paxlovid Treatment
    The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to update healthcare providers, public health departments, and the public on the potential for recurrence of COVID-19 or “COVID-19 rebound.” Paxlovid continues to be recommended for early stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease. A brief return of symptoms may be part of the natural history of SARS-CoV-2 (the virus that causes COVID-19) infection in some persons, independent of treatment with Paxlovid and regardless of vaccination status.
  • Monkeypox: Update about Clinical Diagnosis and Treatment
    This COCA Call will present what clinicians need to know about monkeypox including guidance about the typical clinical presentation, treatment options, pre- and post-exposure prophylaxis, and reporting to public health authorities.
  • COVID-19 Vaccination Modules - NHSN
    This document defines key terms related to COVID-19 vaccination for the purpose of NHSN public health surveillance. Facilities can review these definitions when reporting data through the NHSN COVID-19 Vaccination Modules.
  • Pfizer-BioNT COVID-19 Vaccine: Also Known as COMIRNATY: Overview and Safety -CDC
    After FDA approval, the FDA-authorized Pfizer-BioNTech COVID-19 vaccine for individuals ages 16 years and older was marketed as COMIRNATY. No change was made to the vaccine’s formula with the name change. The Pfizer-BioNTech vaccine label remains for individuals ages 6 months –15 years since the vaccine is authorized but not yet approved for these age groups.

HHS Resources

  • Dietary Guidelines for Americans 2015-2020 Eighth Edition
    The Dietary Guidelines is designed for professionals to help all individuals ages 2 years and older and their families consume a healthy, nutritionally adequate diet. The information in the Dietary Guidelines is used in developing Federal food, nutrition, and health policies and programs.
  • Inpatient Rehabilitation Facility (IRF) Quality Reporting Program (QRP) Training
    CMS offers a web-based training course for those who are new to the IRF QRP, including Lesson 1: What is the IRF QRP?, Lesson 2: The Inpatient Rehabilitation Facility Patient Assessment Instrument (IRF-PAI), Lesson 3: IRF-PAI Data Submission, Lesson 4: IRF QRP Resources.
  • AHRQ Post-Vaccination Practices Series – Learning Modules
    This series of two learning modules (Module 1: Minimizing Infection Risk: Protect, Module 2: Minimizing Infection Risk: Prevent) features strategies to help nursing home teams minimize infection risk in their facility.
  • 988 Suicide & Crisis Lifeline – 988 Partner Toolkit
    SAMHSA recognizes the need for governments, states, territories, tribes, crisis centers, and partners to speak with one voice to ensure there is a clear understanding about what 988 is and how it will work. We encourage you to use these communication outreach materials and build upon them with your community coalitions to meet the needs of your specific audiences.
  • Medicare Diabetes Self-Management Training - CMS
    This training manual contains relevant data and facts, accrediting organization regulations, Diabetes self-management training accrediting organizations, specific accreditation programs, as well as additional resources.
  • COVID-19 Identification and Prevention Series – AHRQ – Learning Modules
    This series of three learning modules focuses on identifying the signs and symptoms of COVID-19, knowing when and how to report signs and symptoms of COVID-19, and remembering to maintain infection prevention processes.
  • Security Risk Assessment Tool
    The Security Risk Assessment tool is designed to help healthcare providers conduct a security risk assessment as required by the HIPAA Security Rule and the Centers for Medicare and Medicaid Service (CMS) Electronic Health Record (EHR) Incentive Program.
  • Implementing a Staff Vaccination Program in Your Nursing Home
    This guide presents important factors nursing home leaders can consider when implementing a staff vaccination program.
  • Revision History for LTC survey process documents and files
    This document will identify revisions made to documents and files that are related to the LTC Survey Process. The revisions will be grouped by effective date
  • OIG – Semiannual Report to Congress October 1, 2021 – March 31, 2022
    Semiannual Report to Congress summarizing the activities of the Department of Health and Human Services (HHS), Office of Inspector General (OIG), for the 6-month period ending on March 31, 2022.

NIH Resources

  • Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
    The Coronavirus Disease 2019 (COVID-19) Treatment Guidelines is published in an electronic format that can be updated in step with the rapid pace and growing volume of information regarding the treatment of COVID-19. The COVID-19 Treatment Guidelines Panel (the Panel) is committed to updating this document to ensure that health care providers, patients, and policy experts have the most recent information regarding the optimal management of COVID-19 (see the Panel Roster for a list of Panel members). New Guidelines sections and recommendations and updates to existing Guidelines sections are developed by working groups of Panel members. All recommendations included in the Guidelines are endorsed by a majority of Panel members (see the Introduction for additional details on the Guidelines development process). Major revisions to the Guidelines within the past month are as follows:
  • NIH - Testing for SARS-CoV-2 Infection
    Everyone who has symptoms that are consistent with COVID-19 and people with known high-risk exposures to SARS-CoV-2 should be tested for SARS-CoV-2 infection. Such testing should employ either a nucleic acid amplification test (NAAT) or an antigen test to detect SARS-CoV-2. Testing may also be used for screening, determining the length of a patient’s isolation period, and other nondiagnostic purposes.
  • COVID-19 Treatment Guidelines – What’s New in the Guidelines
    The Coronavirus Disease 2019 (COVID-19) Treatment Guidelines is published in an electronic format that can be updated in step with the rapid pace and growing volume of information regarding the treatment of COVID-19. The COVID-19 Treatment Guidelines Panel (the Panel) is committed to updating this document to ensure that health care providers, patients, and policy experts have the most recent information regarding the optimal management of COVID-19 (see the Panel Roster for a list of Panel members). New Guidelines sections and recommendations and updates to existing Guidelines sections are developed by working groups of Panel members. All recommendations included in the Guidelines are endorsed by a majority of Panel members (see the Introduction for additional details on the Guidelines development process). Major revisions to the Guidelines within the past month are as follows:
  • Pain Assessment in Hospitalized Older Adults with Dementia and Delirium
    Pain can have negative effects leading to prolonged hospital stays. Determining the presence of uncontrolled and untreated pain in patients with cognitive impairments such as delirium, dementia, and delirium superimposed on dementia (DSD) is challenging. One tool commonly suggested for use in assessment of pain in older adults with cognitive impairment is the Pain Assessment In Advanced Dementia (PAINAD) scale. Proper use of the PAINAD scale as part of a comprehensive pain management plan can help reduce the likelihood of a patient experiencing unrecognized and untreated pain. Using an individual example, this article illustrates best practices in pain assessment and management for a woman experiencing DSD during an acute hospitalization.

Other Outside Resources

  • Disaster Available Supplies in Hospitals (DASH) Tool
    Disaster Available Supplies in Hospitals (DASH) is an interactive tool that can help hospital emergency planners and supply chain staff estimate supplies that may need to be immediately available during various mass casualty incidents (MCI) and infectious disease emergencies based on hospital characteristics.
  • Recommended Adult Immunization Schedule, United States, 2022
    In November 2021, the Advisory Committee on Immunization Practices (ACIP) voted to approve the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2022. The 2022 adult immunization schedule, available at www.cdc.gov/vaccines/schedules/hcp/imz/adult.html, summarizes ACIP recommendations in the cover page, tables, notes, and appendix (Figure).
  • STUMBLING BLOCKS - Identifying and Overcoming Older Adults’ Barriers to Physical Activity
    The goal of this resource is to enhance older adults’ knowledge of available programming and providing education on how to stay active while living with chronic conditions or mobility limitations.
  • Debunking PPE-related myths
    Cardinal Health debunks five PPE related myths.
  • DEMQOL - CH Questionnaire
    The goal of this questionnaire is to assess the resident's feelings, interests, relationships, and their feelings about their everyday activities. There are no right or wrong answers.
  • Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care
    This study provides a proof of concept that DEMQOL-CH can be used to assess HrQoL in NH and AL residents and provides initial indications of feasibility and resources required. DEMQOL-CH may be used to support actions to improve the QoL of residents.
  • More Empathy Means Better Care, Less medical Liability
    The Consultation and Relational Empathy (CARE) Measure is a person-centred process measure that was developed and researched at the Departments of General Practice in Glasgow University and Edinburgh University. The CARE Measure is a quick (only 10 questions), clear and easy to complete patient-completed questionnaire. It measures empathy in the context of the therapeutic relationship during a one-on-one consultation between a clinician and a patient.
  • Clinical Management of COVID-19: Living Guidelines WHO
    The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
  • New Pressure Injury Prevention Guideline Offers Sweeping Recommendations to Protect Patients
    International clinical practice guidelines for the prevention of pressure injuries offer the most comprehensive recommendations issued to date to protect patients at risk for these painful, costly wounds.
  • Delirium Toolkit – Regional Geriatric Program of Toronto
    The SF7 Toolkit is a Senior Friendly Care (sfCare) resource that supports clinical best practices for healthcare providers across the sectors of care and includes self-management tools for older adults and their caregivers.